Author

P. S. Krenger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Zeltins· 2 shared M. F. Bachmann· 2 shared M. O. Mohsen· 2 shared M. Vogel· 2 shared X. Chang· 2 shared A. Manenti· 1 shared A. Nonic· 1 shared A.-C. S. Vogt· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Zeltins

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivDec 20, 2021

Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies

A.-C. S. Vogt, L. Jörg, B. Martina…·M. F. Bachmann

This study compares antibody responses from homologous and heterologous prime-boost vaccination strategies using mRNA and VLP-based vaccines against SARS-CoV-2.

DOI 10.3389/fimmu.2022.864718

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 10, 2021

Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and Variants of Concerns

D. A. Rothen, P. S. Krenger, A. Nonic…·M. O. Mohsen

This study evaluates an intranasally administered VLP-based vaccine in a murine model, showing strong systemic and mucosal antibody responses against SARS-CoV-2 and its variants.

DOI 10.1101/2021.09.10.459749

mouseproteomics

𝕏 PostBluesky